上海莼試生物技術(shù)有限公司
   
菜單 Close 公司首頁(yè) 公司介紹 公司動(dòng)態(tài) 產(chǎn)品展廳 證書(shū)榮譽(yù) 聯(lián)系方式 在線留言
您當(dāng)前的位置: 網(wǎng)站首頁(yè) > 產(chǎn)品展廳 >抗體 >環(huán)指蛋白139抗體費(fèi)用
產(chǎn)品展廳
環(huán)指蛋白139抗體費(fèi)用
  • 品牌:上海莼試
  • 產(chǎn)地:進(jìn)口、國(guó)產(chǎn)
  • 貨號(hào):CS10893
  • 發(fā)布日期: 2019-01-04
  • 更新日期: 2025-04-18
產(chǎn)品詳請(qǐng)
產(chǎn)地 進(jìn)口、國(guó)產(chǎn)
品牌 上海莼試
保存條件 Store at -20 °C
貨號(hào) CS10893
應(yīng)用范圍 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
CAS編號(hào)
抗體名 Anti-RNF139
克隆性
靶點(diǎn) 詳見(jiàn)說(shuō)明書(shū)
適應(yīng)物種 詳見(jiàn)說(shuō)明書(shū)
形態(tài) 詳見(jiàn)說(shuō)明書(shū)
宿主 詳見(jiàn)說(shuō)明書(shū)
亞型 IgG
標(biāo)識(shí)物 詳見(jiàn)說(shuō)明書(shū)
濃度 1mg/1ml%
免疫原 KLH conjugated synthetic peptide derived from human RNF139

抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):

1. 環(huán)指蛋白139抗體費(fèi)用 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件;

3.NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;

4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;

5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性;

6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;

7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用;

8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。

產(chǎn)品訂購(gòu)信息:
英文名稱  Anti-RNF139 

中文名稱   環(huán)指蛋白139抗體費(fèi)用 

      HRCA1; RCA1; Ring finger protein 139; TRC8; RN139_HUMAN.


       1mg/1ml

規(guī)   0.2ml/200μg

抗體來(lái)源   Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, Sheep 

產(chǎn)品類型   一抗  

研究領(lǐng)域     免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo)

蛋白分子量  predicted molecular weight: 76kDa

       Lyophilized or Liquid

 KLH conjugated synthetic peptide derived from human RNF139 

       IgG

純化方法   affinity purified by Protein A

儲(chǔ)    0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

環(huán)指蛋白139抗體費(fèi)用 產(chǎn)品應(yīng)用    WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

(石蠟切片需做抗原修復(fù)) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The protein encoded by this gene is a multi-membrane spanning protein containing a RING-H2 finger. This protein is located in the endoplasmic reticulum, and has been shown to possess ubiquitin ligase activity. This gene was found to be interrupted by a t(3:8) translocation in a family with hereditary renal and non-medulary thyroid cancer. Studies of the Drosophila counterpart suggested that this protein may interact with tumor suppressor protein VHL, as well as with COPS5/JAB1, a protein responsible for the degradation of tumor suppressor CDKN1B/P27KIP.

Function : E3-ubiquitin ligase; acts as a negative regulator of the cell proliferation through mechanisms involving G2/M arrest and cell death. Required for MHC class I ubiquitination in cells expressing the cytomegalovirus protein US2 before dislocation from the endoplasmic reticulum (ER). Affects SREBP processing by hindering the SREBP/SCAP complex translocation from the ER to the Golgi, thereby reducing SREBF2 target gene expression. Required for INSIG1 ubiquitination. May be required for EIF3 complex ubiquitination. May function as a signaling receptor.

Subunit : Interacts with VHL. Interacts with MHC class I and HM13. Component of SCAP/SREBP complex composed of SREBF2, SCAP and RNF139; the complex hampers the interaction between SCAP and SEC24B, thereby reducing SREBF2 proteolytic processing. Interacts with SREBF2 (via C-terminus domain). Interacts with SCAP; the interaction inhibits the interaction of SCAP with SEC24B and hampering the ER to Golgi transport of the SCAP/SREBP complex. Interacts with SEC24B. Interacts with INSIG1 and INSIG2. Interacts with EIF3F and EIF3H; the interaction leads to protein translation inhibitions in a ubiquitination-dependent manner.

Subcellular Location : Endoplasmic reticulum membrane; Multi-pass membrane protein.

Tissue Specificity : Highly expressed in testis, placenta and adrenal gland. Moderate expression in heart, brain, liver, skeletal muscle and pancreas, and low expression in lung and kidney.

Post-translational modifications : Autoubiquitinated. Ubiquitination is induced by sterol and leads to ist degradation via the ubiquitin-proteasome pathway.

DISEASE : Defects in RNF139 may be a cause of renal cell carcinoma (RCC) [MIM:144700]. It is a heterogeneous group of sporadic or hereditary carcinoma derived from cells of the proximal renal tubular epithelium. It is subclassified into clear cell renal carcinoma (non-papillary carcinoma), papillary renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct carcinoma with medullary carcinoma of the kidney, and unclassified renal cell carcinoma. Note=A chromosomal aberration involving RNF139 has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation (3;8)(q14.2;q24.1) with FHIT. RNF139 is found to be fused to FHIT and disrupted within the sterol-sensing domain. In contrast, the FHIT coding region is maintained and expressed. Sporadic cases of renal carcinoma, where an acquired mutation in RNF139 results in the duplication of 12 nucleotides in the 5'-UTR, has also been identified.

Similarity : Contains 1 RING-type zinc finger.

抗體的鑒定:

1環(huán)指蛋白139抗體費(fèi)用 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。

2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力??贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。 

如果所用抗原濃度IC50濃度為pg/,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。

3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。

Irna(Human Immune RNA) ELISA Kit 人免疫核糖核酸Multi-class antibodies規(guī)格: 48T

Anti-phospho-FSCN1(Ser39) 磷酸化纖維束蛋白同源物1抗體Multi-class antibodies規(guī)格: 0.1ml

Rhesus antibody Rh Histone H3 (Di Methyl K4) 二甲基化組蛋白H3K4抗體 規(guī)格 0.1ml

SRP(Human signal recognization particle antibody) ELISA Kit 人抗信號(hào)識(shí)別顆??贵w 96T

recPEP 英文名稱: 重組豬病毒結(jié)構(gòu)蛋白抗體 0.1ml

COMMD3 英文名稱: 銅代謝結(jié)構(gòu)域蛋白3抗體 0.2ml

Anti-phospho-FSCN1(Ser39) 磷酸化纖維束蛋白同源物1抗體Multi-class antibodies規(guī)格: 0.1ml

Anti-RRM1/FITC 熒光素標(biāo)記抗核糖核苷酸還原酶1抗體IgGMulti-class antibodies規(guī)格: 0.2ml

IGF-II( Insulin-like Growth Factor-II ) 樣生長(zhǎng)因子-II(抗原)Multi-class antibodies規(guī)格: 0.5mg

黑素瘤抗原-1抗體 Anti-MAGE-1/HLA-A1 protein 0.2ml

SLC27A2 英文名稱: 長(zhǎng)鏈脂肪酸輔酶A連接酶抗體 0.1ml

FSTL5 英文名稱: 卵泡抑素相關(guān)蛋白5抗體 0.2ml

Rhesus antibody Rh Phospho-Pin1 (Ser16) 磷酸化肽基脯氨酞順?lè)串悩?gòu)酶Pinl抗體 規(guī)格 0.1ml

IGF-II( Insulin-like Growth Factor-II ) 樣生長(zhǎng)因子-II(抗原)Multi-class antibodies規(guī)格: 0.5mg

LIF 大鼠抑制因子Multi-class antibodies規(guī)格: 48T

Anti-ECP 嗜酸性粒細(xì)胞陽(yáng)離子蛋白抗體Multi-class antibodies規(guī)格: 0.2ml

Rhesus antibody Rh MYPT1/MBS 肌球蛋酸酶抗體 規(guī)格 0.1ml

FPA(Human fibrinopeptide A) ELISA Kit 人血纖肽/纖維蛋白肽A 96T

SOX1 英文名稱: 核轉(zhuǎn)錄因子抗體 0.2ml

CCL21 英文名稱: 淋巴細(xì)胞趨化因子CCL21抗體 0.1ml

Anti-ECP 嗜酸性粒細(xì)胞陽(yáng)離子蛋白抗體Multi-class antibodies規(guī)格: 0.2ml

溶菌酶5g炭疽桿菌檢測(cè)用配套試劑

FRASER Listeria Selective Enrichment Broth( base) 1.10398.0500 MERCK默克 incubation media FRASER Listeria Selective Enrichment Broth( base) 1.10398.0500 MERCK默克

改良EC新生霉素增菌肉湯基礎(chǔ)(mEC+n) 250g 用于致病性大腸桿菌O157:H7的增菌培養(yǎng)(GB/T 4789.36-2008, SN/T 1827-2006和SN/T0973-2000)。

兔骨髓間質(zhì)干細(xì)胞成軟骨誘導(dǎo)分化完全培養(yǎng)基Rabbitbonemarrowmesenchymalstemcellsintochondrocytesinduceddifferentiationofcompletemedium

UBA培養(yǎng)基 250g 用于啤酒中厭氧菌檢測(cè)

芽孢桿菌培養(yǎng)基250g用于芽孢桿菌平板計(jì)數(shù)

李斯特菌鑒定顯色培養(yǎng)基 用于將李斯特菌鑒定到種 250ml incubation media 李斯特菌鑒定顯色培養(yǎng)基 用于將李斯特菌鑒定到種 250ml

類干酪乳桿菌類干酪亞種 支/瓶

LST發(fā)酵管(含小倒管)20支/包用于大腸菌群、大腸桿菌的測(cè)定

LactoseBileBroth

環(huán)指蛋白139抗體費(fèi)用 1%NaCl甘露糖  規(guī)格:  20支/盒  用途:  用于鑒別耐的弧菌利用糖源的能力。(鑒定霍亂弧菌)

葡萄糖磷酸鹽胨水生化鑒定管  規(guī)格:  20支/盒  用途:  細(xì)菌生化鑒定

1%NaCl甘露醇生化鑒定管  規(guī)格:  20支/盒  用途:  用于鑒別耐的弧菌利用糖源的能力。(鑒定霍亂弧菌)

蛋白胨水生化鑒定管  規(guī)格:  20支/盒  用途:  細(xì)菌生化鑒定

 


聯(lián)系方式
手機(jī):13585831301
Q Q:
亚洲精品乱码久久久久久久久久久久,国产精品视频色尤物yw,亚洲AV日韩AV永久无码色欲,亚洲a∨精品永久无码